Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul 1;18(7):624-628.
doi: 10.1016/j.jamda.2017.02.009. Epub 2017 Apr 7.

Polypharmacy Is Associated With Higher Frailty Risk in Older People: An 8-Year Longitudinal Cohort Study

Nicola Veronese  1 , Brendon Stubbs  2 , Marianna Noale  3 , Marco Solmi  4 , Alberto Pilotto  5 , Alberto Vaona  6 , Jacopo Demurtas  7 , Christoph Mueller  8 , Jonathan Huntley  8 , Gaetano Crepaldi  3 , Stefania Maggi  3
Affiliations

Polypharmacy Is Associated With Higher Frailty Risk in Older People: An 8-Year Longitudinal Cohort Study

Nicola Veronese et al. J Am Med Dir Assoc. .

Abstract

Objective: To investigate whether polypharmacy is associated with a higher incidence of frailty in a large cohort of North Americans during 8 years of follow-up.

Design: Longitudinal study, follow-up of 8 years.

Participants: A total of 4402 individuals at high risk or having knee osteoarthritis free from frailty at baseline.

Measurements: Details regarding medication prescription were captured and categorized as 0-3, 4-6, and ≥7. Frailty was defined using the Study of Osteoporotic Fracture index as the presence of ≥2 out of (1) weight loss ≥5% between baseline and the subsequent follow-up visit; (2) inability to do 5 chair stands; and (3) low energy level according to the Study of Osteoporotic Fracture definition. Cox's regression models calculating a hazard ratio (HR) with 95% confidence intervals (CIs), adjusted for potential confounders, were undertaken.

Results: During the 8-year follow-up, from 4402 participants at baseline, 361 became frail. Compared with participants taking 0-3 medications, the incidence of frailty was approximately double in those taking 4-6 medications and 6 times higher in people taking ≥7 medications. After adjusting for 11 potential baseline confounders, participants using 4-6 medications had a higher risk of frailty of 55% (HR = 1.55; 95% CI 1.22-1.96; P < .0001), whereas those using more than 7 drugs were at approximately 147% (HR = 2.47; 95% CI 1.78-3.43; P < .0001). Each additional drug used at the baseline increased the risk of frailty at the follow-up of 11% (HR = 1.11; 95% CI 1.07-1.15; P < .0001).

Conclusions: Polypharmacy is associated with a higher incidence of frailty over 8-year follow-up period. Our data suggest evidence of a dose response relationship. Future research is required to confirm our findings and explore underlying mechanisms.

Keywords: Frailty; frail; medication; older adult; polypharmacy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Fig. 1
Fig. 1
Risk of frailty by number of medications at the baseline.
See this image and copyright information in PMC

References

    1. Clegg A, Young J, Iliffe S, et al. Frailty in elderly people. Lancet (London, England) 2013;381:752–762. - PMC - PubMed
    1. Veronese N, Cereda E, Stubbs B, et al. Risk of cardiovascular disease morbidity and mortality in frail and pre-frail older adults: Results from a meta-analysis and exploratory meta-regression analysis. Ageing Res Rev. 2017;35:63–73. - PMC - PubMed
    1. Veronese N, Stubbs B, Fontana L, et al. Frailty is associated with an increased risk of incident type 2 diabetes in the elderly. J Am Med Dir Assoc. 2016;17:902–907. - PubMed
    1. Herr M, Robine JM, Pinot J, et al. Polypharmacy and frailty: Prevalence, relationship, and impact on mortality in a French sample of 2350 old people. Pharmacoepidemiol Drug Saf. 2015;24:637–646. - PubMed
    1. Chang CI, Chan DC, Kuo KN, et al. Prevalence and correlates of geriatric frailty in a northern Taiwan community. J Formos Med Assoc. 2011;110:247–257. - PubMed

Substances

LinkOut - more resources